Federal Rx Budgets Are Argument Against Patent Extensions - Schumer

The increasing spending by federal health programs on pharmaceuticals should inform Congressional action on pharmaceutical patent issues, Sen. Schumer (D-N.Y.) told the Generic Pharmaceutical Industry Association meeting March 27 in New York City.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet